erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
to ensure conscientious dialogue we have implemented a strict no-bullying policy. to participate, you must follow our
.
. it also provides 85 per cent accurate prediction results than current methods.
.
.
"but only when we discovered wet baby car seats in the first summer, we became really excited about the effect of the treatment," she said.
.
share your thoughts
.
sponsored by an innovative medicines canada company